Proto Script Pharmaceutical

Proto Script Pharmaceutical Long-term Debt

Long-Term Debt of Proto Script Pharmaceutical (PSCR) as of Oct 25, 2026.

Long-term Debt

-USD

Last updated:

Long-Term Debt of Proto Script Pharmaceutical is 2026 - USD. Long-Term Debt of Proto Script Pharmaceutical was 2025 - USD. It decreases by % lower compared to the previous year.

The Proto Script Pharmaceutical Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2010
0.00 USD
Jan 1, 2011
0.00 USD
Jan 1, 2012
0.00 USD
Jan 1, 2013
0.00 USD
Jan 1, 2014
0.00 USD
Jan 1, 2015
0.00 USD
The Proto Script Pharmaceutical Long-term Debt history
YEARLong-term DebtYoY
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Proto Script Pharmaceutical Stock analysis

What does Proto Script Pharmaceutical do? Proto Script Pharmaceutical Corp is an American biotechnology company specializing in the development and manufacture of innovative, high-quality drugs. The company is focused on researching new breakthrough technologies in drug manufacturing to find potential cures and treat diseases. Their business model is based on producing medications that are highly effective and of high quality while also being cost-effective and patient-friendly. They collaborate closely with biotechnology companies and academic institutions to acquire the best technologies and develop effective and innovative drugs. They have products in the areas of neurology, endocrine health, and oncology. They have also entered into partnerships with other companies to expand and further develop their products. Overall, Proto Script Pharmaceutical Corp is a groundbreaking company in the biotechnology field with decades of experience in drug development and a commitment to improving the lives of millions of people worldwide. Proto Script Pharmaceutical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Proto Script Pharmaceutical stock

On Eulerpool you can find the complete historical development of Long-Term Debt Proto Script Pharmaceutical since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Proto Script Pharmaceutical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Proto Script Pharmaceutical

All Key Metrics — Proto Script Pharmaceutical